glp 1 pill novo nordisk Oral GLP-1 Wegovy chases approval in obesity Novo Nordisk launches Wegovy weight-loss

Reconstituted solution must be refrigerated

Gradual dose escalation reduces nausea, vomiting, and other gastrointestinal side effects

Medical weight loss requires addressing fat oxidation, hormonal balance, and cellular metabolism concurrently

The FDA's 2023 guidance on antidiabetic drug development considers a 0.3 percentage point difference versus active comparator as clinically meaningful

Liposomal glutathione formulations emerged in the late 1990s and early 2000s, using phospholipid bilayers to protect the tripeptide from enzymatic degradation in the GI tract

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing pioglitazone therapy in patients with type 2 diabetes: a 24-week, multicenter, randomized, double-blind, placebocontrolled, parallel-group study